• Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

What do we really know about new drugs?NPS News 37: Mind the gaps: how much do we really know about new drugs?

Description: Suggests a cautious approach to new drugs, given the limitations of evidence, lack of safety profiles in clinical trials and side effects seen in postmarketing surveillance.

Download PDF now (4 pages, 104.7 KB )
news37_new_drugs_1204.pdf
Date published: 2004-12-01 00:00:00
Download Adobe Acrobat Reader

This document is a PDF file. To view PDF documents you will need to download Adobe Reader from the Adobe website.

Please don't show me this PDF gateway page again for this browser session (this will reset when the browser is closed).

Date published: 2004-12-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.